Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Avalo Therapeutics (AVTX) Receivables - Net (2016 - 2023)

Avalo Therapeutics' Receivables - Net history spans 8 years, with the latest figure at $38000.0 for Q2 2023.

  • For Q2 2023, Receivables - Net fell 93.01% year-over-year to $38000.0; the TTM value through Jun 2023 reached $38000.0, down 93.01%, while the annual FY2021 figure was $1.1 million, 51.31% down from the prior year.
  • Receivables - Net reached $38000.0 in Q2 2023 per AVTX's latest filing, down from $544000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $5.0 million in Q3 2019 to a low of $38000.0 in Q2 2023.
  • Average Receivables - Net over 5 years is $2.1 million, with a median of $2.0 million recorded in 2020.
  • Peak YoY movement for Receivables - Net: soared 117.34% in 2020, then tumbled 93.01% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $1.0 million in 2019, then surged by 117.34% to $2.2 million in 2020, then crashed by 51.31% to $1.1 million in 2021, then plummeted by 48.68% to $544000.0 in 2022, then crashed by 93.01% to $38000.0 in 2023.
  • Per Business Quant, the three most recent readings for AVTX's Receivables - Net are $38000.0 (Q2 2023), $544000.0 (Q2 2022), and $938000.0 (Q1 2022).